Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Villani

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
Tumori|April 30, 1986
Cardiac arrhythmia: possible complication from treatment with cisplatinL Canobbio, T Fassio, G Gasparini, et al.
Journal of Photochemistry and Photobiology. B, Biology|June 3, 2000
Hypericin photosensitization of tumor and metastatic cell lines of human prostateA Colasanti, A Kisslinger, R Liuzzi, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1986
New anthracycline analogs in advanced breast cancerV Bonfante, L Ferrari, C Brambilla, et al.
Lasers in Surgery and Medicine|June 22, 2000
MS-2 fibrosarcoma characterization by laser induced autofluorescenceA Colasanti, A Kisslinger, G Fabbrocini, et al.
The International Journal of Biological Markers|January 14, 2005
Genetic heterogeneity of variable number tandem repeats in thymidylate synthase gene in colorectal cancer patientsM Agostini, S Pulciarelli, S Pucciarelli, et al.
Lancet (London, England)|July 20, 1991
Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR)M Zeviani, C Gellera, C Antozzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Activity and toxicity of 4'-iodo-4'-deoxydoxorubicin in patients with advanced breast cancerL Gianni, G Capri, M Greco, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Prevention of doxorubicin-induced cardiomyopathy by reduced glutathioneF Villani, M Galimberti, F Zunino, et al.
Applied Optics|June 8, 2018
Evaluation of the PMMA microlens efficiency for the realization of a solar micro-concentrator arrayF Loffredo, F Villani, C Cancro, et al.
Tumori|December 31, 1987
A phase I study of recombinant interleukin 2 in melanoma patients. Toxicity and clinical effectsR Marolda, F Belli, A Prada, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
Tumori|April 30, 1986
Cardiac arrhythmia: possible complication from treatment with cisplatinL Canobbio, T Fassio, G Gasparini, et al.
Journal of Photochemistry and Photobiology. B, Biology|June 3, 2000
Hypericin photosensitization of tumor and metastatic cell lines of human prostateA Colasanti, A Kisslinger, R Liuzzi, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1986
New anthracycline analogs in advanced breast cancerV Bonfante, L Ferrari, C Brambilla, et al.
Lasers in Surgery and Medicine|June 22, 2000
MS-2 fibrosarcoma characterization by laser induced autofluorescenceA Colasanti, A Kisslinger, G Fabbrocini, et al.
The International Journal of Biological Markers|January 14, 2005
Genetic heterogeneity of variable number tandem repeats in thymidylate synthase gene in colorectal cancer patientsM Agostini, S Pulciarelli, S Pucciarelli, et al.
Lancet (London, England)|July 20, 1991
Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR)M Zeviani, C Gellera, C Antozzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Activity and toxicity of 4'-iodo-4'-deoxydoxorubicin in patients with advanced breast cancerL Gianni, G Capri, M Greco, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Prevention of doxorubicin-induced cardiomyopathy by reduced glutathioneF Villani, M Galimberti, F Zunino, et al.
Applied Optics|June 8, 2018
Evaluation of the PMMA microlens efficiency for the realization of a solar micro-concentrator arrayF Loffredo, F Villani, C Cancro, et al.
Tumori|December 31, 1987
A phase I study of recombinant interleukin 2 in melanoma patients. Toxicity and clinical effectsR Marolda, F Belli, A Prada, et al.
Pageof 20